Here, we have chosen to assess the less well-known synthetic diarylidenylpiperidone curcumin analog, designated HO-3867, for the purpose of rescuing the suppression of the expression of the oncogene PLAC1 in ovarian cancer cells harboring a missense TP53 mutation. This evidence concerns the gene PLAC1 and ovarian carcinoma.